During the past decade, Jacksonville Heart Center conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 2 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Jacksonville Heart Center" #1 sponsor was "Baim Institute for Clinical Research" with 1 trials, followed by "Cogentus Pharmaceuticals" with 1 trials sponsored, "Forest Laboratories" with 1 trials sponsored, "Gilead Sciences" with 1 trials sponsored and "Otsuka Pharmaceutical Development & Commercialization, Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Jacksonville Heart Center" #1 collaborator was "Abbott" with 1 trials as a collaborator, "Boston Scientific Corporation" with 1 trials as a collaborator, "Bristol-Myers Squibb" with 1 trials as a collaborator, "Cordis Corporation" with 1 trials as a collaborator and "Daiichi Sankyo, Inc." with 1 trials as a collaborator. Other collaborators include -2 different institutions and companies that were collaborators in the rest 8 trials.

According to Clinical.Site data, the most researched conditions in "Jacksonville Heart Center" are "Coronary Artery Disease" (3 trials), "Acute Coronary Syndrome" (1 trials), "Angina Pectoris" (1 trials), "Arrhythmia" (1 trials) and "Congestive Heart Failure" (1 trials). Many other conditions were trialed in "Jacksonville Heart Center" in a lesser frequency.

Most popular intervention types in "Jacksonville Heart Center" are "Drug" (5 trials) and "Genetic" (1 trials). Other intervention types were less common.

The name of intervention was led by "Azimilide Dihydrochloride" (1 trials), "CGT-2168 (clopidogrel 75 mg/omeprazole 20 mg) and aspirin" (1 trials), "Clopidogrel & Aspirin, Prasugrel & Aspirin" (1 trials), "Placebo" (1 trials) and "Placebo & Aspirin" (1 trials). Other intervention names were less common.

The vast majority of trials in "Jacksonville Heart Center" are 6 trials for "All" genders.

Currently, there are NaN active trials in "Jacksonville Heart Center". undefined are not yet recruiting, undefined are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Jacksonville Heart Center, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Jacksonville Heart Center, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".